Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (2)

Aichi Medical University School of Medicine: Nagakute, Aichi, JP

2017-06-01 to present | Professor (Department of Pathology)
Employment
Source: Self-asserted source
Kenji Kasai

Aichi Medical University School of Medicine: Nagakute, Aichi, JP

1995-11-01 to 2017-05-31 | Associate Professor (Department of Pathology)
Employment
Source: Self-asserted source
Kenji Kasai

Education and qualifications (3)

National Institutes of Health: Bethesda, Maryland, US

1995-11-01 to 2000-10-31 | Visiting Scientist (Developmental Neurogenetics, NINDS)
Education
Source: Self-asserted source
Kenji Kasai

Aichi Cancer Center Research Institute: Nagoya, JP

1992-04-01 to 1995-10-31 | Visiting Researcher (Laboratory of Immmunology)
Education
Source: Self-asserted source
Kenji Kasai

Nagoya University Graduate School of Medicine: Nagoya, Aichi, JP

1988-04-01 to 1992-03-31 | MD, Ph.D (Department of Pathology)
Education
Source: Self-asserted source
Kenji Kasai

Professional activities (4)

The Molecular Biology Society of Japan: Tokyo, Tokyo, JP

Membership
Source: Self-asserted source
Kenji Kasai

Japanese Breast Cancer Society: Tokyo, Tokyo, JP

Membership
Source: Self-asserted source
Kenji Kasai

Japanese Cancer Association: Tokyo, Tokyo, JP

2001-04-01 to present
Membership
Source: Self-asserted source
Kenji Kasai

The Japan Society of Pathology: Tokyo, Tokyo, JP

1988-04-01 to present
Membership
Source: Self-asserted source
Kenji Kasai

Funding (1)

Cell cycle regulation of triple-negative breast cancer by newly-identified nuclear protein network

2019-04 to 2022-03 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 19K07449
Source: Self-asserted source
Kenji Kasai

Works (14)

The <i>MCPH7</i> Gene Product STIL Is Essential for Dendritic Spine Formation

Cells
2025-01 | Journal article | Author
DOI: 10.3390/cells14020062
Contributors: Tohru Matsuki; Hidenori Tabata; Masashi Ueda; Hideaki Ito; Koh-ichi Nagata; Yumi Tsuneura; Shima Eda; Kenji Kasai; Atsuo Nakayama
Source: check_circle
Multidisciplinary Digital Publishing Institute

CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness

The Journal of Pathology
2020-02 | Journal article
DOI: 10.1002/path.5361
Part of ISSN: 0022-3417
Part of ISSN: 1096-9896
Source: Self-asserted source
Kenji Kasai

Indispensable role of STIL in the regulation of cancer cell motility through the lamellipodial accumulation of ARHGEF7–PAK1 complex

Oncogene
2020-02 | Journal article
DOI: 10.1038/s41388-019-1115-9
Part of ISSN: 0950-9232
Part of ISSN: 1476-5594
Source: Self-asserted source
Kenji Kasai

Diffuse mesothelin expression leads to worse prognosis through enhanced cellular proliferation in colorectal cancer

Oncology Letters
2020-01-10 | Journal article
DOI: 10.3892/ol.2020.11290
Part of ISSN: 1792-1074
Part of ISSN: 1792-1082
Source: Self-asserted source
Kenji Kasai

CD70 expression in tumor-associated fibroblasts predicts worse survival in colorectal cancer patients

Virchows Archiv
2019-10 | Journal article
DOI: 10.1007/s00428-019-02565-1
Part of ISSN: 0945-6317
Part of ISSN: 1432-2307
Source: Self-asserted source
Kenji Kasai

Down-regulation of the zinc-finger homeobox protein TSHZ2 releases GLI1 from the nuclear repressor complex to restore its transcriptional activity during mammary tumorigenesis

Oncotarget
2016-02-02 | Journal article
DOI: 10.18632/oncotarget.6788
Part of ISSN: 1949-2553
Source: Self-asserted source
Kenji Kasai

GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells

Oncotarget
2015-10-20 | Journal article
DOI: 10.18632/oncotarget.5203
Part of ISSN: 1949-2553
Source: Self-asserted source
Kenji Kasai

Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2

Oncotarget
2015-09-29 | Journal article
DOI: 10.18632/oncotarget.4960
Part of ISSN: 1949-2553
Source: Self-asserted source
Kenji Kasai

GLI1 Interferes with the DNA Mismatch Repair System in Pancreatic Cancer through BHLHE41-Mediated Suppression of MLH1

Cancer Research
2013-12-15 | Journal article
DOI: 10.1158/0008-5472.can-13-2008
Part of ISSN: 0008-5472
Part of ISSN: 1538-7445
Source: Self-asserted source
Kenji Kasai

GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin

Oncogene
2011-02 | Journal article
DOI: 10.1038/onc.2010.459
Part of ISSN: 0950-9232
Part of ISSN: 1476-5594
Source: Self-asserted source
Kenji Kasai

SCL/TAL1 Interrupting Locus Derepresses GLI1 from the Negative Control of Suppressor-of-Fused in Pancreatic Cancer Cell

Cancer Research
2008-10-01 | Journal article
DOI: 10.1158/0008-5472.can-07-6661
Part of ISSN: 0008-5472
Part of ISSN: 1538-7445
Source: Self-asserted source
Kenji Kasai

A role of activated Sonic hedgehog signaling for the cellular proliferation of oral squamous cell carcinoma cell line

Biochemical and Biophysical Research Communications
2004-02 | Journal article
DOI: 10.1016/j.bbrc.2003.12.097
Part of ISSN: 0006-291X
Source: Self-asserted source
Kenji Kasai

The G12 family of heterotrimeric G proteins and Rho GTPase mediate Sonic hedgehog signalling

Genes to Cells
2004-01 | Journal article
DOI: 10.1111/j.1356-9597.2004.00701.x
Part of ISSN: 1356-9597
Part of ISSN: 1365-2443
Source: Self-asserted source
Kenji Kasai

A general method to design dominant negatives to B-HLHZip proteins that abolish DNA binding

Proceedings of the National Academy of Sciences
1997-11-11 | Journal article
DOI: 10.1073/pnas.94.23.12274
Part of ISSN: 0027-8424
Part of ISSN: 1091-6490
Source: Self-asserted source
Kenji Kasai

Peer review (1 review for 1 publication/grant)

Review activity for Oncogene. (1)
How many people are using ORCID?